Abiopharma

HPE Names Chris Hsu to Board of Directors

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

8x8, Inc. Announces Participation in Evercore Global TMT Conference

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Merlin, Inc. To Participate in Upcoming Investor Conferences

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tredegar Announces Bonnell Aluminum Leadership Changes

Forgent Power Solutions Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis